 MALVERN, Pa., Sept. 01, 2022 GLOBE NEWSWIRE -- TELA Bio, Inc. TELA, a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patients own anatomy, today announced that it will participate in two upcoming investor conferences. 